Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
about
Investigational drugs in recent clinical trials for treatment-resistant depression.A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocMicroRNAs as CNS Drug Targets.
P2860
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mirtazapine added to selective ...... a randomised controlled trial.
@en
type
label
Mirtazapine added to selective ...... a randomised controlled trial.
@en
prefLabel
Mirtazapine added to selective ...... a randomised controlled trial.
@en
P2093
P2860
P50
P1433
P1476
Mirtazapine added to selective ...... a randomised controlled trial.
@en
P2093
David Kessler
Debbie Tallon
John Campbell
Simon Gilbody
Una Macleod
William Hollingworth
P2860
P2888
P356
10.1186/S13063-016-1199-2
P50
P577
2016-02-03T00:00:00Z
P6179
1013360118